No Data
No Data
On July 19th, Gilead Sciences-B (01672) spent approximately HKD 0.8067 million to repurchase 0.747 million shares.
Galepharmaceutical-B (01672) announced that on July 19, 2024, the company will invest about 80.67 million yuan...
On July 18, GALENEO PHARMACEUTICALS-B (01672.HK) spent 0.0305 million Hong Kong dollars to repurchase 0.029 million shares.
On July 18th, Ge Li Pharmaceutical -B (01672.HK) announced that it spent 0.0305 million Hong Kong dollars to repurchase 0.029 million shares.
Galepharmaceuticals spent HKD 0.5612 million on repurchasing 0.541 million shares on July 17.
Galephar Pharmaceutical-B (01672) issued an announcement that the company spent HKD 0.5612 million to repurchase 0.541 million shares on July 17, 2024, at a repurchase price of HKD 1.02-1.04 per share.
On July 17th, Geri Pharmaceutical-B (01672.HK) spent HKD 0.561 million to buy back 0.541 million shares.
On July 17th, Gerui Pharmaceuticals - B (01672.HK) announced that it spent HKD 0.561 million to repurchase 0.541 million shares.
Galepharmaceutical-B spent 2.4478 million Hong Kong dollars to repurchase 2.492 million shares on July 15th.
Galea Pharmaceuticals-B (01672) announced in a statement that on July 15, 2024, the company spent 2.4478 million Hong Kong dollars to repurchase 2.492 million shares.
On July 15th, Gilead Sciences B (01672.HK) spent 2.45 million Hong Kong dollars to repurchase 2.492 million shares.
On July 15th, Gerui Pharmaceutical -B (01672.HK) announced the repurchase of 2.492 million shares for a cost of HKD 2.45 million.
No Data